Michael has over 20 years experience in marketing, business development, and product development in the medical products industry. He has worked in a variety of marketing, sales, clinical research, and product development roles with companies such as JNJ (cardiovascular devices), Covidien (cardiovascular imaging), and BD (vascular access). He has had key executive roles on both the manufacturing and distribution sides of the medical products industry. His expertise and background is concentrated in the following areas:
- Managed Care Organizations
- Pharmaceuticals
- Medical devices
- Medical products distribution
- Single-use medical devices
- Oncology
- Cardiology
- Primary care
- Long-term care
- Hospice
- Point of care, CLIA-waived diagnostic testing
- Medical device product development
- Clinical research
- Mergers and acquisitions
- Sales development
- Healthcare IT
- iPhone healthcare applications
Training
For medical device analysts or non-US organizations attempting to enter the US market, Michael can provide a training session over the phone or in person on a variety of key topics:
- Group Purchasing Organizations. What and who are they, how pricing is established, who are the key leaders, and how they are key gatekeepers to US market access.
- Distributors. How products enter into and are moved out into the market.
- Marketing and sales. What are the key issues, methods, and strategies to bring medical devices to the US market?
- Competitive profiles.
- Market opportunities.
Selected publications
Meneveau N, Schiele F, Grollier G, Farah B, Lablanche JM, Khalifé K, Machecourt J, Danchin N, Wolf JE, Simpson M, Hak JB, Bassand JP (2000) ‘’Local delivery of nadroparin for the prevention of neointimal hyperplasia following stent implantation: results of the IMPRESS trial. A multicentre, randomized, clinical, angiographic and intravascular ultrasound study.’’ European Heart Journal 21 (21):1767–75. Full text.